Your OEM-Developer for Medical and Diagnostic Devices
Do you have a product idea or do you want to launch a started development onto the market within the shortest possible time? Then we are your perfect full-service OEM partner more
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Do you have a product idea or do you want to launch a started development onto the market within the shortest possible time? Then we are your perfect full-service OEM partner more
Mobile phone speakers and motion detectors in cars and video games may soon be powered by electricity generated from low cost and sustainable biomaterials, according to research carried out at University of Limerick (UL), Ireland. Scientists at UL's Bernal Institute have discovered that the biomolec more
Siemens AG is preparing to list its separately managed healthcare unit on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. This move, which the company's Supervisory Board approved at its meeting today, is planned for the first half of 2018. "For Siemens Healthineers, t more
Experts at Queen’s University Belfast have designed a flexible and organic alternative to the rigid batteries that power up medical implants. Currently, devices such as pacemakers and defibrillators are fitted with rigid and metal based batteries, which can cause patient discomfort. Dr Geetha Sriniv more
The demarcation between medicinal products and devices is becoming evermore important. In addition, with the convergence of emerging novel technologies the number of drug/device combination products and medical devices incorporating a medicinal substance are increasing. At the same time cell therapy
Description: Course "A Risk Based Approach To Data Integrity" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. The impact of Data Integrity issues on a regulated company can be significant: it can result in recalls of p
Global Engage is pleased to announce the Global Cyber Security in Healthcare & Pharma Summit 2018, which will be taking place 3rd & 4th May 2018 in London. The conference will be co-located with the Blockchain in Healthcare Congress 2018. The number of cyber-attacks in healthcare is on the rise, and
Process Risk Manager (f/m) Full Time Heidenheim an der Brenz, Deutschland With Professional-Experience 11/8/17 The HARTMANN GROUP is one of the leading European providers of medical and hygiene products with core competences in wound treatment, incontinence care and infection protection. The more
Product Risk Manager (f/m) Full Time Heidenheim an der Brenz, Deutschland With Professional-Experience 11/8/17 The HARTMANN GROUP is one of the leading European providers of medical and hygiene products with core competences in wound treatment, incontinence care and infection protection. The more
Abstract The interaction of blood proteins with an implant surface is not only a fundamental phenomenon but is also key to several important medical complications. Plasma proteins binding on the surface of intravascular catheters can promote bacterial adhesion leading to the risk of local and sy more
Additive manufacturing (AM) is poised to radically change the way objects are manufactured, ranging from critical applications such as aircraft components and medical devices to more commonplace, yet highly engineered, products such as running shoes. The ability to produce three-dimensional (3D) obj more
Medium chain-length polyhydroxyalkanoates (mPHAs) are flexible elastomeric biopolymers with valuable properties for biomedical applications like artificial arteries and other medical implants. However, an environmentally friendly and high productivity process together with the tuning of the mechanic more
BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 2012 should more
BMI View: On account of its unpredictable and unfavourable operating environment and limited funding for and investment in healthcare and medicines, Zimbabwe’s pharmaceutical market will remain unattractive to foreign companies for the foreseeable future. Poor healthcare provision and coverage will more
BMI View: We retain our negative outlook for the pharmaceutical market in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear (y-o-y) decrease calculated for 2011. While the increase in the value-added tax (VAT) will negate th more
Watchlist
This is where you can add this topic to your personal favourites